The prevalence of depressive disorder and its association in Thai cervical cancer patients

Abstract

Purpose The purpose of this study is to examine the prevalence, associated factors and quality of life associated with depressive disorder in cervical cancer patients. Patients and methods This cross-sectional study was carried out in a gynecologic oncology clinic of a university hospital in Northern Thailand from October 2018 to August 2019. Two-hundred cervical cancer patients were screened for depressive disorder using the nine-item Patient Health Questionnaire (PHQ-9), and psychiatrists interviewed eligible patients to confirm diagnoses. We measured the quality of life using questionnaires from the European Organisation for the Research and Treatment of Cancer: Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and Cervical Cancer Module 24 (EORTC QLQ-Cx24). Associated factors, including comorbidity, fatigue, and pain, were collected using the Charlson Comorbidity Index (CCI), the eleven-item Chalder Fatigue Scale (CFQ 11), and the visual analog scale (VAS) for pain, respectively. Results Twenty-seven (13.5%) cervical cancer patients were diagnosed with depressive disorder by psychiatrists according to the DSM-5. Depressive disorder was related to a worse quality of life in these patients. A binary logistic regression analysis revealed that depressive disorder among these patients was linked with these factors: high fatigue score (aOR: 1.35; CI: 1.18–1.53), high pain score (aOR: 1.25; CI: 1.02–1.54), no perception of social support, (aOR: 3.12; CI: 1.11–8.81), and no previous surgical treatment for cervical cancer (aOR: 2.99; CI: 1.08–8.29). Conclusion The depressive disorder prevalence was 13.5% in Northern Thai cervical cancer patients. In this demographic, cervical cancer patients—who reported high fatigue or pain scores, did not perceive social support, or had no previous cervical cancer surgery- were more likely to have depressive disorder.

The Association of HHV-6 and the TNF-α (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand

“…The prevalence of HHV-6 infection, the TNF-α (-308G/A) promotor mutation, and MDD patients in Asia are shown in Table 4. G/G = 181 (92.1%) G/A = 19 (7.9%) A/A = 0 (0.0%) [68] 13.5% [69] 3.7% G/G = 209 (98.1%) G/A = 4 (1.9%) A/A = 0 (0.0%) G/G = 249 (96.1%) G/A = 10 (3.9%) A/A = 0 (0.0%) [76] 17% [77] PBMC qPCR 0.6% 0.2% [78] G…”

Anxiety and depression versus pain sensation in patients with gynecological cancers

“…The diagnosis of neoplastic disease and the need to undergo anti-neoplastic treatment are significant sources of stress for patients. A crisis related to the disease and treatment is a serious burden for patients and may lead to the development of anxiety and depressive disorders [25,26].…”

“…Rozpoznanie choroby nowotworowej i konieczność poddania się leczeniu przeciwnowotworowemu są istotnymi źródłami stresu dla pacjenta. Kryzys związany z chorobą i leczeniem jest poważnym obciążeniem dla chorego, a także może prowadzić do rozwoju zaburzeń lękowych i depresyjnych [25,26].…”